NOVARTIS INDIA
Back to Cashflow Statement
|
NOVARTIS INDIA Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-64 Cr | ₹-121 Cr | ₹-30 Cr | ₹-36 Cr | ₹-37 Cr |
What is the latest Cash Flow from Financing Activities ratio of NOVARTIS INDIA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-64 Cr |
| Mar2024 | ₹-121 Cr |
| Mar2023 | ₹-30 Cr |
| Mar2022 | ₹-36 Cr |
| Mar2021 | ₹-37 Cr |
How is Cash Flow from Financing Activities of NOVARTIS INDIA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-64 Cr | Negative | |
| Mar2024 | ₹-121 Cr | Negative | |
| Mar2023 | ₹-30 Cr | Negative | |
| Mar2022 | ₹-36 Cr | Negative | |
| Mar2021 | ₹-37 Cr | - | |
Compare Cash Flow from Financing Activities of peers of NOVARTIS INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NOVARTIS INDIA | ₹2,344.5 Cr | 1.1% | 14.3% | 19.4% | Stock Analytics | |
| ADANI ENTERPRISES | ₹253,405.0 Cr | -2% | -12.3% | -8.1% | Stock Analytics | |
| REDINGTON | ₹18,332.6 Cr | 0.6% | -12.8% | -2.1% | Stock Analytics | |
| HONASA CONSUMER | ₹8,754.1 Cr | -6.3% | -8% | 26.1% | Stock Analytics | |
| MMTC | ₹7,984.5 Cr | -2.6% | -19.6% | 0.8% | Stock Analytics | |
| LLOYDS ENTERPRISES | ₹7,272.5 Cr | 1.3% | -17.9% | 20.9% | Stock Analytics | |
NOVARTIS INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NOVARTIS INDIA | 1.1% |
14.3% |
19.4% |
| SENSEX | -5.5% |
-11.5% |
0.3% |
You may also like the below Video Courses